Dawei Chen
Impact in
- Pharmaceutical Science top 0.1%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 71
- Advanced biosensing and bioanalysis techniques 23
- Lipid Membrane Structure and Behavior 9
- Biomaterials 83
- Nanoparticle-Based Drug Delivery 76
- Co-authors
- Haiyang Hu (103 shared papers)Mingxi Qiao (79 shared papers)Xiuli Zhao (75 shared papers)Jiulong Zhang (28 shared papers)Lifang Cheng (12 shared papers)Jing Qin (3 shared papers)Lipeng Qiu (11 shared papers)Lixiang Ren (1 shared paper)
- Journals
- International Journal of Pharmaceutics (15 papers)Acta Biomaterialia (13 papers)Journal of Controlled Release (11 papers)International Journal of Nanomedicine (10 papers)ACS Applied Materials & Interfaces (8 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Dawei Chen
222 papers receiving 7.8k citations
Peers
Comparison fields: 5 of 150
- Pharmaceutical Science 1.3k
- Biomaterials 2.7k
- Molecular Medicine 445
- Biomedical Engineering 2.2k
- Molecular Biology 2.9k
Countries citing papers authored by Dawei Chen
This map shows the geographic impact of Dawei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Chen more than expected).
Fields of papers citing papers by Dawei Chen
This network shows the impact of papers produced by Dawei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Chen. The network helps show where Dawei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 228 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 352 | |
| 2 | 2017 | 254 | |
| 3 | 2005 | 246 | |
| 4 | 2013 | 166 | |
| 5 | 2019 | 156 | |
| 6 | 2006 | 150 | |
| 7 | 2014 | 144 | |
| 8 | 2013 | 125 | |
| 9 | 2016 | 122 | |
| 10 | 2002 | 108 | |
| 11 | 2017 | 104 | |
| 12 | 2013 | 100 | |
| 13 | 2008 | 98 | |
| 14 | 2014 | 97 | |
| 15 | 2014 | 93 | |
| 16 | 2015 | 93 | |
| 17 | 2019 | 92 | |
| 18 | 2012 | 92 | |
| 19 | 2007 | 90 | |
| 20 | 2016 | 86 |
About Dawei Chen
Dawei Chen is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Pharmaceutical Science and Oncology, having authored 228 papers that have together received 7.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (76 papers), RNA Interference and Gene Delivery (71 papers), Nanoplatforms for cancer theranostics (55 papers), Advanced Drug Delivery Systems (26 papers), Dendrimers and Hyperbranched Polymers (24 papers), Advanced biosensing and bioanalysis techniques (23 papers), Immune cells in cancer (12 papers) and Lipid Membrane Structure and Behavior (9 papers). The work is most often cited by research in Pharmaceutical Science (1.3k citations), Biomaterials (2.7k citations), Molecular Medicine (445 citations), Biomedical Engineering (2.2k citations) and Molecular Biology (2.9k citations). Dawei Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Haiyang Hu, Mingxi Qiao, Xiuli Zhao, Jiulong Zhang, Lifang Cheng, Jing Qin, Lipeng Qiu, Lixiang Ren, Yifan Luo and Xinlong Zang. Their work appears in journals such as International Journal of Pharmaceutics, Acta Biomaterialia, Journal of Controlled Release, International Journal of Nanomedicine and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.